Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft scoping review: change in lean mass during… — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-017/3
Series
Public comment period
Version
1.0
Published
21 Jul 2026
Last reviewed
21 Jul 2026
Next review
21 Jul 2027
Identifier
10.71829/cei.cp.17
Certainty
Not rated
Cycle
2026 Q2
Window
08 May 2026 – 22 Jun 2026
Status
Closed
Submissions
7

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-LEAN-MASS-SC/007Dr Georgiana MountstephenResults at materially different follow-up durations are pooledAccepted
DRAFT-LEAN-MASS-SC/003Dr Liesbeth QuennevilleThe review does not say when it will be updated or what would trigger an updateAccepted
DRAFT-LEAN-MASS-SC/002Dr Ottoline Fitzgerald-NwosuThe review protocol is described but its registration record is not linkedAccepted in part
DRAFT-LEAN-MASS-SC/004Dr Dmitri NordhagenThe same concern is used to downgrade in two domainsAccepted in part
DRAFT-LEAN-MASS-SC/001Dr Zebedee Zaleski-MbekiAnalytical surveys are treated as evidence about suppliers when they establish only what was in a sampleAccepted
DRAFT-LEAN-MASS-SC/006Dr Ludmila TollemacheAbsence of evidence is presented in a form a reader will take as negative evidenceAccepted
DRAFT-LEAN-MASS-SC/005Dr Jolyon Grünbaum-SowandeBaseline imbalance in a small contributing trial is not remarked onNoted, no amendment
7 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted4The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part2Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment1The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted0The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. Results at materially different follow-up durations are pooled — arising from DRAFT-LEAN-MASS-SC/007. Estimates are now reported by duration band, with the number of contributing trials and participants in each band stated, and no estimate is pooled across bands.
  2. The review does not say when it will be updated or what would trigger an update — arising from DRAFT-LEAN-MASS-SC/003. Every synthesis now records a scheduled review date and a stated update trigger, being the reporting of a trial that would materially change the contributing evidence, and the registered trials capable of triggering an update are listed by name.
  3. The review protocol is described but its registration record is not linked — arising from DRAFT-LEAN-MASS-SC/002. Each synthesis now links its own protocol with the version in force at screening, and states explicitly where an external registration identifier is not held, so that the absence is a recorded fact.
  4. The same concern is used to downgrade in two domains — arising from DRAFT-LEAN-MASS-SC/004. The rating for the first outcome has been raised by one level and the domain reasoning restated, and the reasoning for the second has been rewritten to make clear that the two downgrades rest on different features of the evidence.
  5. Analytical surveys are treated as evidence about suppliers when they establish only what was in a… — arising from DRAFT-LEAN-MASS-SC/001. Provenance is now assessed for every included survey and reported as a study characteristic, surveys without establishable provenance are reported separately rather than pooled with those that have it, and no supplier-level inference is drawn from a…
  6. Absence of evidence is presented in a form a reader will take as negative evidence — arising from DRAFT-LEAN-MASS-SC/006. A standing formulation has been adopted and is applied wherever an evidence gap is recorded, distinguishing an outcome assessed and not demonstrated from an outcome not assessed. The formulation is identical at every occurrence so that it can be recognised at…

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.